George Staphos

Stock Analyst at B of A Securities

(2.32)
# 2,663
Out of 5,072 analysts
306
Total ratings
51.67%
Success rate
-8.67%
Average return

Stocks Rated by George Staphos

Sylvamo
Nov 17, 2025
Upgrades: Buy
Price Target: $41$59
Current: $48.03
Upside: +22.84%
O-I Glass
Nov 17, 2025
Upgrades: Buy
Price Target: $14$17
Current: $13.13
Upside: +29.47%
Ball Corporation
Nov 17, 2025
Upgrades: Buy
Price Target: $61
Current: $49.38
Upside: +23.53%
Karat Packaging
Nov 17, 2025
Downgrades: Underperform
Price Target: $27$22
Current: $21.88
Upside: +0.55%
PotlatchDeltic
Nov 17, 2025
Downgrades: Underperform
Price Target: $49$46
Current: $39.89
Upside: +15.32%
Weyerhaeuser Company
Nov 17, 2025
Downgrades: Neutral
Price Target: $29$26
Current: $22.14
Upside: +17.43%
Greif
Sep 2, 2025
Maintains: Neutral
Price Target: $77$71
Current: $64.21
Upside: +10.57%
Greif
Sep 2, 2025
Maintains: Neutral
Price Target: $77$71
Current: $69.27
Upside: +2.50%
Silgan Holdings
Aug 28, 2025
Upgrades: Buy
Price Target: $53$57
Current: $39.48
Upside: +44.38%
International Paper Company
Aug 28, 2025
Upgrades: Buy
Price Target: $55$57
Current: $39.13
Upside: +45.67%
Maintains: Buy
Price Target: $110$117
Current: $97.04
Upside: +20.57%
Maintains: Buy
Price Target: $31$28
Current: $16.11
Upside: +73.81%
Maintains: Buy
Price Target: $195$208
Current: $170.49
Upside: +22.00%
Maintains: Buy
Price Target: $111$107
Current: $75.44
Upside: +41.83%
Maintains: Buy
Price Target: $66$71
Current: $41.57
Upside: +70.80%
Maintains: Buy
Price Target: $42$39
Current: $43.35
Upside: -10.03%
Maintains: Underperform
Price Target: $73$75
Current: $81.38
Upside: -7.84%
Maintains: Buy
Price Target: $197$200
Current: $201.26
Upside: -0.63%
Downgrades: Underperform
Price Target: $4.1$3.5
Current: $3.75
Upside: -6.67%
Upgrades: Buy
Price Target: $51$65
Current: $80.77
Upside: -19.52%
Downgrades: Underperform
Price Target: $12$9
Current: $8.51
Upside: +5.76%
Maintains: Buy
Price Target: $132$152
Current: $123.44
Upside: +23.14%
Maintains: Buy
Price Target: $26$24
Current: $6.50
Upside: +269.23%